CellBri is a biotechnology company specializing in advanced manufacturing solutions for cell therapies. We focus on developing automated, closed, digital, and regulatory-compliant systems for cell processing and fill-and-finish operations. Partnering with CellBri enables academic institutions, biotechnology firms, and pharmaceutical companies in the cell therapy field to accelerate drug development, enhance manufacturing capabilities, reduce process failures, lower production costs, and meet global patient needs. Headquartered in Shenzhen, China, CellBri is a global company with additional facilities in Beijing, Shanghai and Research Triangle Park, North Carolina, USA.
There is no investment information
No recent news or press coverage available for CellBri.